WARF ADVANCES
Top licensing prospects from the University of Wisconsin-Madison
Novel Methods for In Vivo Cell Tracking
This novel cell radiolabeling technology involves chemical modifications of surface glycans and tracks the in vivo fate of cells using PET imaging.
Read more
A High Throughput Newborn Screening Assay for Angelman and Prader-Willi Syndromes
This higher throughput method to detect the methylation pattern of the alleles involved in Prader-Willi and Angelman disorders provides a means of screening for these disorders in newborn dried blood spots at state testing labs.
Read more
Single Sensor Tensiometer
The compact shear wave sensor employs a single sensor/actuator pair to provide a smaller skin contact footprint suitable for a wider variety of tissue measurements, including stress that ligaments, tendons or muscle experience in vivo.
Read more
Hemoglobin-Based Nanoparticles
UW-Madison researchers have developed a multi-functional antibiotic nanoparticle that incorporates hemoglobin and the clinically approved antifungal agent naftifine in the core, which is coated with red blood cell membranes.
Read more
Advancing T Cell-Based Immunotherapies
New methods and technologies developed by researchers at UW-Madison aim to improve the process of producing biologic drugs — such as CAR T cells — at every stage, from the manufacturing process to therapeutic application.
Read more
Read about more licensing prospects!
Featured UW-Madison Researcher
 |
Megan McClean, Associate Professor of Biomedical Engineering
“Innovative companies are excited by Megan’s research and want to collaborate with her. We are excited to see her inventions commercialized.” – Jennifer Gottwald, WARF Director of Licensing |
In the News